Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Thursday, March 12, 2015

NeuralStem Inc. Announces Topline Results Of Phase II Als Trial

The study met primary safety endpoints. The maximum tolerated dose of 16 million transplanted cells and the surgery was well tolerated.

http://ift.tt/18Dp0VN

No comments:

Post a Comment

Popular Stem Cell Roundup Posts